TY  - JOUR

T1  - First clinical study of the novel platelet ADP receptor (P-2 gamma) antagonist AR-C69931MX, assessing safety, tolerability and activity in patients with acute coronary syndromes

JO  - CIRCULATION

PY  - 1999/11/02

AU  - Storey RF

AU  - Oldroyd KG

AU  - Wilcox RG

ED  - 

VL  - 100

IS  - 18

SP  - 710

EP  - 710

Y2  - 2024/12/22

ER  -